Physician profile
Norris E March
NPI 1295744225
$2,067.65
in general payments reported to CMS, 2019-2025
26 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.64 · 2020: $15.57 · 2022: $443 · 2023: $420 · 2024: $576 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,548.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $416.57 | 2022-2025 | Collagenase Santyl, Grafix Pl, Oasis |
| Abbvie INC. | $275.22 | 2022-2025 | |
| Heron Therapeutics, INC. | $153.31 | 2022-2025 | Zynrelef, Aponvie |
| Intuitive Surgical, INC. | $118.36 | 2022 | |
| Organogenesis INC. | $115.65 | 2024-2025 | Apligraf |
| Urgo Medical North America, LLC | $103.41 | 2024-2025 | Urgoclean Ag, Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ethicon US, LLC | $101.10 | 2019-2024 | Echelon Endopath, Surgicel Nu-Knit, Echelon Circular |
| Convatec INC. | $95.10 | 2019-2024 | |
| Melinta Therapeutics, LLC | $73.32 | 2019-2024 | Orbactiv, Kimyrsa |
| Hartmann USA, INC. | $71.02 | 2024-2025 | Zetuvit Plus 10x10 P10 |
| Janssen Biotech, INC. | $64.72 | 2025 | Tremfya |
| Mimedx Group, INC. | $57.02 | 2024-2025 | |
| Novo Nordisk INC | $56.25 | 2024-2025 | Wegovy |
| Olympus America INC. | $49.73 | 2023-2025 | Olympus, Hd 3cmos Autoclavable Camera Head |
| Stryker Corporation | $43.61 | 2023 | Spy-Phi System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $42.07 | 2022-2024 | Spyglass Discover |
| Kerecis Limited | $40.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Reprise Biomedical, INC. | $39.70 | 2024-2025 | Miro3d |
| Aroa Biosurgery Incorporated | $32.87 | 2022 | |
| Kci USA, INC. | $20.54 | 2023 | Activ.A.C. |
| Surgenex LLC | $20.38 | 2025 | Surgraft, Ardeograft, Renograft |
| Medtronic, INC. | $20.11 | 2023 | Signia |
| Eagle Pharmaceuticals, INC. | $15.57 | 2020 | |
| Sanara Medtech INC. | $15.03 | 2024 | Celleraterx |
| Integra Lifesciences Corporation | $14.68 | 2023 | Tcc-Ez |
| Hologic Sales and Service, LLC | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norris March listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.